|
|
|
Press Release: Int'l Pharma and Medical Device Compliance Congress XI Features Keynote by OECD Director Directorate for Legal Affairs Nicola Bonucci, DEA, DESS, LLM
|
- Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
- Co-sponsored by the Pharmaceutical Compliance Forum
- May 15 - 17, 2017
- Onsite at the Lisbon Marriott Hotel, Lisbon, Portugal
- www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com |
|
FEATURING
|
Nicola Bonucci, DEA, DESS, LLM
Director, Directorate for Legal Affairs, OECD, Paris, France
|
|
CONGRESS HOTEL SOLD OUT
|
|
Click here for overflow hotels.
|
|
|
LISBON, PORTUGAL -- PHARMA UPDATE NEWS SERVICE™ -- MAY 3, 2017: The Eleventh International Pharmaceutical and Medical Device Compliance Congress, www.InternationalPharmaCongress.com, to be held May 15 - 17, 2017 at the Lisbon Marriott Hotel in Lisbon, Portugal, today announced the conference dates and a call for proposals.
|
|
KEYNOTE SPEAKERS
|
Nicola Bonucci, DEA, DESS, LLM
Director, Directorate for Legal Affairs, OECD, Paris, France |
Charles Cain, Esq.
Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC |
Thomas Cueni
Director General, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland
|
Agustín Puente Escobar, Esq.
Head, Legal Cabinet, Spanish Agency for Data Protection, Madrid, Spain |
Tarek Helou, Esq.
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, U.S. Department of Justice, Washington, DC, USA |
Rui Santos Ivo
Vice president, INFARMED (Portugal National Authority on Medicines and Health Products), Member of the Management Board, European Medicines Agency (EMA), Lisbon, Portugal
|
George “Ren” McEachern,
CFE, CAMS
Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA |
Sophie Peresson, LLM, MSc
Global Health Policy Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, Former Regional Director, International Diabetes Federation European Region, London, UK |
Marie-Claire Pickaert
Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium
|
Aleksandar Rusanov, Esq.
Legal Advisor, Legal Department, European Medicines Agency (EMA), London, United Kingdom |
Neill Stansbury, Esq.
Co-founder and Director of the Global Infrastructure Anti-Corruption Centre, Chair, International Organization for Standardization Anti-Bribery Project Committee, Vice Chair, Anti-corruption Standing Committee, World Federation of Engineering Organization, Buckinghamshire, UK
|
|
|
|
CO CHAIRS
|
Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France |
Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France
|
Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France |
Roeland Van Aelst
Regional Vice President – HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
|
|
|
|
FEATURING CHIEF COMPLIANCE OFFICERS
|
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former Vice President, Chief Compliance Officer, Dendreon, Former Associate General Counsel; Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA |
Sujata Dayal, JD
Vice President, Health Care Compliance and Privacy, Global Chief Compliance Officer, Pharmaceuticals, Johnson and Johnson, Former Chief Compliance Officer and Corporate Vice President, Biomet, Inc., Former Ethics and Compliance Officer, Abbott Laboratories, Titusville, NJ, USA |
Martin Fuerle, MBA
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany
|
Lori V. Queisser, CPA
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Philadelphia, PA, USA |
Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark
|
|
|
|
EFPIA CODES TRAINING WORKSHOP
|
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is offering an independent EFPIA CODES TRAINING WORKSHOP on Monday, May 15, 2017.
|
|
FEATURED FACULTY
|
Ted Acosta, Esq.
Americas Vice Chair, Risk Management, EY; Former Senior Counsel, Office of Inspector General, United States Department of Health and Human Services, New York, NY, USA and Paris, France |
David Andersen
Partner, Pharmaceuticals and Life Sciences, PwC, London, UK |
Michael Bartke, PhD
Former Director Compliance Management, Daiichi Sankyo Europe GmbH, Munich, Germany
|
Ann Beasley, JD
Director, Healthcare and Life Sciences Disputes, Compliance & Investigations, Navigant Consulting, Former Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis, Boston, MA, USA |
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA |
Peter W.L. Bogaert, MA, LJ
Partner, Covington & Burling LLP, Brussels, Belgium
|
Rifat Bozacioglu
Area Compliance Director, Middle East, GlaxoSmithKline plc, Istanbul, Turkey |
Chrissy Bradshaw, JD
Vice President, Porzio Life Sciences, LLC, Morristown, NJ, USA |
Anne-Sophie Bricca
Deputy General Counsel, Senior Director Law and Compliance, EMEA, Terumo BCT, Brussels, Belgium
|
Anna Byrom, LLM
Associate Director, Compliance EUCA, Intercept Pharmaceuticals, Former Associate Director, Astellas Pharma Europe, London, United Kingdom |
Jeffrey Campbell, JD
President and Chief Executive Officer, Porzio Life Sciences, Porzio Life Sciences, LLC, Morristown, NJ |
Grant H. Castle, Esq.
Partner, Covington & Burling LLP, London, United Kingdom
|
Holger Diener, PhD
Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry, Berlin, Germany |
Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, United Kingdom
|
Karen Eryou
Head, Ethics & Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium |
George Fife
Partner, Fraud Investigation & Dispute Services, EY; Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France |
Pedro Caridade de Freitas, LLM, PhD
Legal and Compliance Director, Portuguese Association of the Pharmaceutical Industry (APIFARMA), Lisbon, Portugal
|
Geert van Gansewinkel
Managing Partner, Europe and Asia Pacific, Polaris, Amsterdam, Netherlands |
Dominik Geller
Head Pharma Healthcare Compliance Office, Roche, Basel, Switzerland |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
|
Michael Alan Gleave
Compliance Officer, Corporate Compliance and CSR, H. Lundbeck A/S, Copenhagen, Denmark |
Filipa Godinho
Business Consultant, Global Transparency, Eli Lilly and Company, Lisbon, Portugal |
Cécile Gousset
Head of Compliance Risk Assessment, Policies & Education, Global Ethics & Business Integrity, Sanofi, Paris, France
|
Ulf H. Grundmann, Esq.
Partner, Life Sciences Practice Group, King & Spalding LLP, Frankfurt am Main, Germany |
Joe Henein, Pharm.D.
President and Chief Executive Officer, NewBridge Pharmaceuticals FZ LLC, Dubai, United Arab Emirates |
Chris J Holmes
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant, London, United Kingdom
|
Casey Horton
Director, Healthcare and Life Sciences Disputes, Regulatory Compliance and Investigations, Navigant, Chicago, IL, USA |
Bella Rafael Hovhannisyan
Compliance Director, Intercontinental Commercial Operations, CSL Behring, Former Compliance and Ethics Lead, Spain, Portugal, and Nordic Region, Bristol-Myers Squibb, Bern, Switzerland |
Rajiv Joshi, ICAI, ISACA, CIA, CFE
Partner, Fraud Investigation & Dispute Services, EY, Mumbai, India
|
Carl Judge
Partner, Fraud Investigation & Dispute Services, EY, London, UK |
Anita K. Kim-Reinartz
Partner, Fraud Investigation & Dispute Services, EY, Düsseldorf, Germany |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC
|
Kirtis Kraeuter, MGA
Head, Worldwide Compliance Committee and Monitoring Center of Expertise, Bristol-Myers Squibb, Princeton, NJ, USA |
Edoardo Lazzarini, PhD
Compliance Initiatives Director EUCAN, Takeda Pharmaceuticals International, Former Compliance Officer EMEA (Europe, Middle East & Africa), Biomet, Milano, Italy |
William Long, LLB
Partner, Sidley Austin LLP, London, United Kingdom
|
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC |
Abdul Luheshi, MBA
Executive Director, Global Operations, Ethics & Compliance, Astellas Pharma EMEA, Former Vice President, Health Care Compliance, Johnson & Johnson, Chertsey, UK |
Marcel Maderitsch, LLM
Senior Compliance Officer, Vifor Pharma, Zürich, Switzerland
|
Maureen McGirr, JD
Vice President, Office of Ethics, Global Compliance Organization, Merck, Sharp, and Dohme, Kenilworth, NJ, USA |
Sofie Melis
Senior Manager, Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland |
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie – CIS, Limited, Moscow, Russia
|
Audrey Mills, JD
Sr. Director Ethics and Compliance and Chief Privacy Officer, Eli Lilly and Company, Indianapolis, IN, USA |
Laura Nassar
Head of Compliance, Middle East, Roche Pharmaceuticals, Dubai, United Arab Emirates |
Chrisoula Nikidis
Executive Director, Ethics and Compliance, Innovative Medicines Canada; Industry Co-Chair Designate, APEC Biopharmaceutical Working Group on Ethics, Ottawa, Canada
|
Michael O’Connor
Senior Director, Global Head Ethics and Compliance Operations, Alexion Pharmaceuticals, Inc., Cheshire, CT |
David O’Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK |
Pascale Paimbault
Executive Director, EMEA Ethics and Compliance, ABAC, Astellas Pharma Europe; Former Compliance Officer, France -Benelux, Biogen, Treasurer and Strategic Committee Member, ETHICS; Former Chief Compliance Officer EMEA, Wright Medical Inc.; Former Senior Director, Compliance and Ethics, Business Program, EMEA, Bristol-Myers Squibb, Paris, France
|
Giota Papamarkou
Global Ethics & Compliance Director, Ipsen, Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France |
Ima Parrondo
Health Care Compliance Officer EMEA-C, Janssen Pharmaceutical Companies of Johnson & Johnson, Madrid, Spain |
Debolina Partap, BCOM, LLM
General Counsel, Wockhardt, Mumbai, India
|
Oscar Perdomo
Director, Pharmaceuticals and Life Sciences, PwC, Switzerland |
Jessica Pfennig, EMBA, MLS
Global Commercial Operations, Global Digital Governance Director, AstraZeneca, Wilmington, Delaware, USA |
Ariadna Quesada, MPP
Compliance Manager Europe, Middle-East and Africa, MicroPort Orthopedics Inc., Amsterdam, Netherlands
|
Gabriela Radu
Compliance Lead & Data Privacy Officer at Amgen Romania; Former Ethics and Compliance Associate, Eli Lilly and Company, Bucharest, Romania |
Jose Ramos, MD, MBA
Compliance Officer for Italy, Portugal, and Spain, Biogen, Former Ethics and Compliance Officer, Eli Lilly, Madrid, Spain |
Vivian Robinson, Esq.
Queen’s Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Former Treasurer of Inner Temple, London, UK
|
Fabien Roy, DESS
Senior Associate, Hogan Lovells, Member, EFGCP-MedTech Europe Working Party, Brussels, Belgium |
Dream Samir
Consultant, AMICULUM-ME, Secretary General, Pharmaceutical Research and Manufacturers Association, Gulf (PhRMAG),, Dubai, United Arab Emirates |
Daniel Schafaghi
Global Compliance Operating Officer, Head of Compliance Emerging Markets, Boehringer Ingelheim GmbH, Ingelheim, Germany
|
Brian Sharkey, JD
Vice President, Porzio Life Sciences, LLC, Morristown, NJ, USA |
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, United Kingdom |
Michele Tagliaferri, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium
|
Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, EY, London, UK |
Yuet Ming Tham, JD
Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance, Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong |
Tamara Tubin, lic. iur.
Compliance Director EUCAN, Takeda Pharmaceuticals International AG; Former Corporate Compliance Director, Biogen International; Former Ethics and Compliance Director International, Carefusion, Zurich, Switzerland
|
Ken Walsh, MA, MSc
Director, Life Sciences Consulting, Navigant, London, United Kingdom |
Frank Wartenberg, PhD
President, Central Europe, IMS Health, Lecturer, Health Care Management Institute, EBS Business School, Frankfurt/Main, Germany |
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland
|
Elisabethann Wright, Esq.
Partner, Hogan Lovells International LLP, Brussels, Belgium |
Jolanta Wyszynska
Vice President, Compliance Europe, AstraZeneca, Warsaw, Poland
|
Maged Zaki, MD
Health Care Compliance Officer; Europe, Middle East and Africa, Johnson and Johnson Global R&D, Dubai, United Arab Emirates |
Jose F. Zamarriego Izquierdo, PhD
Director Unidad de Supervision Deontologica, Farmainidustria, Madrid, Spain
|
|
|
|
2017 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.InternationalPharmaCongress.com
|
|
NATIONAL MEDICAL AFFAIRS COMPLIANCE SUMMIT
|
The Leading Forum on Compliance Issues Related to Medical Affairs Activities of Pharmaceutical and Medical Device Companies
June 26 - 27, 2017
Hyatt Regency Crystal City
Arlington, VA
www.MedicalAffairsSummit.com
|
|
SECOND PHARMACEUTICAL SUMMIT ON BUSINESS AND COMPLIANCE ISSUES IN MANAGED MARKETS
|
The Leading Forum on Pharmaceutical
Market Access, Reimbursement, Pricing, and Contracting with Commercial and Government Payers
June 27 - 28, 2017
Hyatt Regency Crystal City
Washington, DC
www.PharmaManagedMarketsSummit.com
|
|
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.AsianPharmaCongress.com
|
|
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
November 14 - 16, 2017
Mumbai, India
www.IndianPharmaCongress.com
|
|
|
|
|
SPECIAL ETHICS/PCF REGISTRATION DISCOUNT:
- SAVE UP TO €400 -
|
Click here for Special Pharmaceutical Compliance Forum (PCF) Member Registration Discount.
|
|
SPONSORED BY:
|
|
|
CO-SPONSORED BY:
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNER
|
|
|
CONTINUING EDUCATION CREDITS
|
Accounting Professionals: Approved for up to 17.0 NASBA CPE credits.
Compliance Professionals: Approved for 22.20 Compliance Certification Board CCB credits.
Attorneys: Pending approval for PA MCLE credits.
Click here for more information.
|
|
FOLLOW INTERNATIONAL PHARMA CONGRESS ON
|
Tweet using #PharmaCongress
|
|
INTERNATIONAL PHARMA CONGRESS IS
|
|
|
2017 INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
|
|
CO-CHAIRS
|
Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France
Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France
Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen, President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
|
|
MEMBERS
|
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former Vice President, Chief Compliance Officer, Dendreon, Former Associate General Counsel; Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA
Michael Bartke, PhD
Former Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Munich, Germany
Ann Beasley, JD
Director, Healthcare and Life Sciences Disputes, Compliance & Investigations, Navigant Consulting, Former Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis, Boston, MA, USA
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA
Leonardo Cassara A. Silva, LLM
Global Compliance Officer, Ferring International Center S.A., Former Head of Compliance, Acino Pharma AG, Former Compliance Director, Emerging Markets, Takeda Pharmaceuticals, Saint-Prex, Switzerland
Sujata Dayal
Vice President, Health Care Compliance and Privacy, Global Chief Compliance Officer, Pharmaceuticals, Johnson & Johnson, Former Chief Compliance Officer and Corporate Vice President, Biomet, Inc.,Former Ethics and Compliance Officer, Abbott Laboratories, Titusville, NJ, USA
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
Martin Fuerle, MBA
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
Ulf H. Grundmann, Esq.
Partner, King and Spalding, Frankfurt am Main, Germany
Kirtis Kraeuter, MGA
Head, Worldwide Compliance Committee and Monitoring Center of Expertise, Bristol-Myers Squibb, Princeton, NJ, USA
Evelyne Lemaire
Head of Compliance, Europe & Canada, Takeda Pharmaceuticals International GmbH, Former Director, Global Pharmaceutical and Life Sciences, PwC LLP, Zurich, Switzerland
Abdul Luheshi, MBA
Executive Director, Global Operations, Ethics & Compliance, Astellas Pharma EMEA, Former Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Compliance Congress, Chertsey, UK
Maureen McGirr, JD
Vice President, Office of Ethics, Global Compliance Organization, Merck, Sharp, and Dohme, Kenilworth, NJ, USA
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia
Laura Nassar
Head of Compliance, Middle East, Roche Pharmaceuticals, Dubai, UAE
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA
David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK
Maria-Teresa Rico Pérez, MD
Europe and Canada Regional Compliance Officer, Biogen, Zug, Switzerland
Marie-Claire Pickaert, MA
Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium
Ariadna Quesada, MPP
Compliance Manager Europe, Middle-East and Africa, MicroPort Orthopedics Inc., Amsterdam, Netherlands
Uffe Kåre Rasmussen, MSc
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S,, Copenhagen, Denmark
Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, London, UK
Hubertus Stockmann, MBA
Divisional Compliance Officer, Merck KgaA, Frankfurt, Germany
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland
Elisabethann Wright, Esq.
Partner, Hogan Lovells International LLP, Brussels, Belgium
Jolanta Wyszynska
Vice President, Compliance Europe, AstraZeneca, Warsaw, Poland
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, Farmainidustria, Madrid, Spain
|
|
OTHER INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
2012 - São Paulo
2013 - Madrid, Spain
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
2014 - Mexico City
2014 - Shanghai
2015 - Manila
2016 - Warsaw
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
|
|
|
|
|
|
